Expert Outlook: Beauty Health Through The Eyes Of 4 Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have shared their insights on Beauty Health (NASDAQ:SKIN), with opinions ranging from indifferent to somewhat bearish. The average 12-month price target has declined from $2.50 to $1.44, reflecting a 42.4% decrease. Recent analyst actions include downgrades and lowered price targets, indicating a cautious outlook on the company's performance.
August 12, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Beauty Health (NASDAQ:SKIN) has seen a decline in analyst sentiment over the past three months, with recent downgrades and a significant drop in the average 12-month price target from $2.50 to $1.44. This reflects a cautious outlook on the company's performance.
The decline in analyst sentiment, coupled with recent downgrades and a significant drop in the average price target, suggests a negative short-term impact on Beauty Health's stock price. Analysts have lowered their expectations due to the company's recent financial performance and market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100